Missed a dose?
Don't worry!

You can take your
Rhopressa® the
next day

Common Questions

Everything you need to know about Rhopressa®.
All in one place.

What is Rhopressa®?

Rhopressa® (netarsudil ophthalmic solution) 0.02% is an FDA-approved prescription eye drop used for the treatment of elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

How often do I take Rhopressa®?

Rhopressa® should only be taken once a day, at night. Do not administer Rhopressa® more than once a day.

Can I use Rhopressa® with other eye drop medications?

When Rhopressa® is used with another medication, it is recommended to wait at least 5 minutes. Please consult with your doctor if you have specific questions or concerns about any medications you're currently taking.

Are there any possible side effects I should know about Rhopressa®?

The most common side effect was eye redness. 80% of the time, when eye redness occurred, it was mild and sporadic. The redness did not tend to get worse over time. Other common side effects are small deposits in the outer eye surface, mild installation pain, and broken blood vessels in the white of the eye. Please see full Rhopressa® Prescribing Information for a full list of possible side effects.

Should I stop taking my eye drops if my eye becomes red?

No. Do not stop taking your eye drops unless your doctor has told you to stop. You should contact your eye doctor if you have a concern about any side effects.

How do I store Rhopressa®?

Rhopressa® may be stored at room temperature (36°F to 77°F) for up to 6 weeks. If after opening, the product is kept refrigerated at 36°F to 46°F, then the product can be used until the expiration date stamped on the bottle.

To prevent contamination of the solution, avoid touching the tip of the container to the eyes, fingers, or any surface. Serious damage to the eye and possible loss of vision may result from using contaminated solutions.

Are there any financial assistance options for Rhopressa®?

Rhopressa® offers a savings card that helps eligible patients with commercial insurance save on their out-of-pocket costs. Learn more about the Rhopressa® Savings Card.

Ask your doctor if Rhopressa® is right for you

Jump-start the conversation at your next eye appointment

Use the questions below to help guide the conversation during your next eye appointment

  • 1Are there any new treatments that I can add to my existing glaucoma or ocular hypertension treatment?
  • 2What makes Rhopressa® different from other glaucoma or ocular hypertension medications?
  • 3Is it true that Rhopressa® can be used with any other eye drop medications I may be taking?
  • 4Would a once-daily prescription eye medication like Rhopressa® be beneficial for me?
  • 5Are there any possible side effects I should be aware of while taking Rhopressa®?

Download the Rhopressa® Savings Card today!

It's a quick and easy way to help eligible patients save on their out-of-pocket costs!

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Bacterial Keratitis: Avoid allowing the tip of the bottle to touch the eye to avoid bacterial eye infection which has been reported with the use of multiple-dose containers of topical ophthalmic products.

Contact Lenses: Contact lenses should be removed prior to using Rhopressa® and may be reinserted 15 minutes following its administration.

ADVERSE REACTIONS

The most common ocular adverse reaction observed in controlled clinical studies with Rhopressa® dosed once daily was red eyes, in 53% of patients. Six percent of patients discontinued therapy due to red eyes. Other common (approximately 20%) adverse reactions were: small deposits on the outer surface of the eye, mild pain upon instillation, and broken blood vessels on the white of the eye. Instillation site redness, corneal staining, blurred vision, increased tearing, redness of eyelid, and reduced visual acuity were reported in 5-10% of patients.

The small deposits on the outer surface of the eye seen in Rhopressa®-treated patients were first noted at 4 weeks of daily dosing. This reaction did not result in any apparent visual functional changes. Most small deposits on the outer surface of the eye resolved upon discontinuation of treatment.

Please see full Rhopressa® Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

INDICATION

Rhopressa® (netarsudil ophthalmic solution) 0.02% is a prescription medication for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

DOSAGE AND ADMINISTRATION

The recommended dosage is one drop in the affected eye(s) once daily in the evening.

+

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Bacterial Keratitis: Avoid allowing the tip of the bottle to touch the eye to avoid bacterial eye infection which has been reported with the use of multiple-dose containers of topical ophthalmic products.

Contact Lenses: Contact lenses should be removed prior to using Rhopressa® and may be reinserted 15 minutes following its administration.

ADVERSE REACTIONS

The most common ocular adverse reaction observed in controlled clinical studies with Rhopressa® dosed once daily was red eyes, in 53% of patients. Six percent of patients discontinued therapy due to red eyes. Other common (approximately 20%) adverse reactions were: small deposits on the cornea, mild pain upon instillation, and broken blood vessels on the white of the eye. Instillation site redness, corneal staining, blurred vision, increased tearing, redness of eyelid, and reduced visual acuity were reported in 5-10% of patients.

The small deposits on the outer surface of the eye seen in Rhopressa®-treated patients were first noted at 4 weeks of daily dosing. This reaction did not result in any apparent visual functional changes. Most small deposits on the outer surface of the eye resolved upon discontinuation of treatment.

Please see full Rhopressa® Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

INDICATION

Rhopressa® (netarsudil ophthalmic solution) 0.02% is a prescription medication for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

DOSAGE AND ADMINISTRATION

The recommended dosage is one drop in the affected eye(s) once daily in the evening.